Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer.
García-Ortiz MV, Cano-Ramírez P, Toledano-Fonseca M, Cano MT, Inga-Saavedra E, Rodríguez-Alonso RM, Guil-Luna S, Gómez-España MA, Rodríguez-Ariza A, Aranda E. García-Ortiz MV, et al. Among authors: aranda e. Clin Epigenetics. 2023 Jul 22;15(1):118. doi: 10.1186/s13148-023-01535-4. Clin Epigenetics. 2023. PMID: 37481552 Free PMC article.
Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy.
Guil-Luna S, Rivas-Crespo A, Navarrete-Sirvent C, Mantrana A, Pera A, Mena-Osuna R, Toledano-Fonseca M, García-Ortíz MV, Villar C, Sánchez-Montero MT, Krueger J, Medina-Fernández FJ, De La Haba-Rodríguez J, Gómez-España A, Aranda E, Rudd CE, Rodríguez-Ariza A. Guil-Luna S, et al. Among authors: aranda e. Biomed Pharmacother. 2023 Nov;167:115592. doi: 10.1016/j.biopha.2023.115592. Epub 2023 Sep 29. Biomed Pharmacother. 2023. PMID: 37778272 Free article.
Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.
Brozos-Vázquez E, Toledano-Fonseca M, Costa-Fraga N, García-Ortiz MV, Díaz-Lagares Á, Rodríguez-Ariza A, Aranda E, López-López R. Brozos-Vázquez E, et al. Among authors: aranda e. Cancer Treat Rev. 2024 Apr;125:102719. doi: 10.1016/j.ctrv.2024.102719. Epub 2024 Mar 12. Cancer Treat Rev. 2024. PMID: 38490088 Free article. Review.
Ibero-American Consensus Review and Incorporation of New Biomarkers for Clinical Practice in Colorectal Cancer.
Bonilla CE, Montenegro P, O'Connor JM, Hernando-Requejo O, Aranda E, Pinto Llerena J, Llontop A, Gallardo Escobar J, Díaz Romero MDC, Bautista Hernández Y, Graña Suárez B, Batagelj EJ, Wali Mushtaq A, García-Foncillas J. Bonilla CE, et al. Among authors: aranda e. Cancers (Basel). 2023 Sep 1;15(17):4373. doi: 10.3390/cancers15174373. Cancers (Basel). 2023. PMID: 37686649 Free PMC article. Review.
Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial.
García-Alfonso P, Elez E, Soto-Alsar J, Páez D, Fernández-Montes A, Graña B, Salud A, Yubero A, Gómez-España MA, Macías I, Quintero G, López-López C, Fernández-Rodríguez T, Grávalos C, González-Flores E, Guix M, García Paredes B, Reina JJ, Rodríguez Mowbray JR, Sastre J, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD). García-Alfonso P, et al. Among authors: aranda e. ESMO Open. 2024 Dec;9(12):103986. doi: 10.1016/j.esmoop.2024.103986. Epub 2024 Nov 27. ESMO Open. 2024. PMID: 39608305 Free PMC article. Clinical Trial.
457 results